1 terminated, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Facial Paralysis: new trials by email Literature Review of Facial Paralysis trials Research Report on Facial Paralysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair. NTX-001 - Facial Paralysis | Phase 2 | Terminated | Neuraptive Therapeutics Inc. | 2 | 2022-07-12 | 2023-09-11 |
| Onabotulinumtoxin A and Hyaluronic Acid Fillers in the Treatment of Facial Paralysis Juvederm, Vistabex - Hemifacial Paralysis | Phase 2 | Unknown | Azienda Ospedaliera Universitaria Integrata Verona | 70 | 2021-07-14 | 2022-05-16 |
Mouth Diseases (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Paralysis (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Stomatognathic Diseases (2)
Botulinum Toxins (1) · Botulinum Toxins, Type A (1)
Azienda Ospedaliera Universitaria Integrata Verona (1) · Neuraptive Therapeutics Inc. (1)
Italy (1) · United States (1)
Dario Bertossi, Prof (1) · Seth Schulman, MD (1)